法伯精诚国药匠心——国药控股与皮尔法伯制药达成战略合作

国药控股12-02

近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股副总裁、总法律顾问、首席合规官胡立刚，皮尔法伯制药首席执行官高雅睿（MARIE-ANDRÉE GAMACHE）出席并见证签约，国药控股全球采购与供应链服务中心总经理孔学东与皮尔法伯制药中国区总裁黄田伟代表双方签约。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588093980?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-02 10:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2588093980","market":"hk","top_or_hot":-1,"title":"法伯精诚 国药匠心——国药控股与皮尔法伯制药达成战略合作","media":"国药控股","content":"<div>\n<p>近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股副总裁、总法律顾问、首席合规官胡立刚，皮尔法伯制药首席执行官高雅睿（MARIE-ANDRÉE GAMACHE）出席并见证签约，国药控股全球采购与供应链服务中心总经理孔学东与皮尔法伯制药中国区总裁黄田伟代表双方签约。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>法伯精诚 国药匠心——国药控股与皮尔法伯制药达成战略合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n法伯精诚 国药匠心——国药控股与皮尔法伯制药达成战略合作\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-02 10:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b><strong>国药控股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股副总裁、总法律顾问、首席合规官胡立刚，皮尔法伯制药首席执行官高雅睿（MARIE-ANDRÉE GAMACHE）出席并见证签约，国药控股全球采购与供应链服务中心总经理孔学东与皮尔法伯制药中国区总裁黄田伟代表双方签约。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0640798160.USD","symbol_name":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b","article_id":"2588093980","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588093980","pubTimestamp":1764641863,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。与国药控股这一行业巨头建立战略伙伴关系，是其深耕中国市场的重要里程碑。国药控股无与伦比的渠道覆盖和市场领导力，将极大提升皮尔法伯制药产品的可及性。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","01099":"国药控股","BK1197":"保健护理产品经销商","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1500":"做空集合股","BK1191":"制药","BK1515":"抗疫概念","BK1574":"生物医药B类股","01477":"欧康维视生物-B"},"translate_title":"Farber's sincerity and Sinopharm's ingenuity-Sinopharm Holdings and Pierre Farber Pharmaceuticals reach a strategic cooperation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01477":1.5,"01099":1.5},"content_text":"近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股副总裁、总法律顾问、首席合规官胡立刚，皮尔法伯制药首席执行官高雅睿（MARIE-ANDRÉE GAMACHE）出席并见证签约，国药控股全球采购与供应链服务中心总经理孔学东与皮尔法伯制药中国区总裁黄田伟代表双方签约。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。皮尔法伯制药在药品生产领域拥有卓越的产品研发能力和强大的品牌影响力，国药控股是中国医疗健康产品龙头分销商零售商以及领先的供应链服务提供商。相信通过双方的强强联合、优势互补，能够加速将皮尔法伯的创新产品惠及更广泛的中国患者，共同推动中国健康产业的发展与升级。高雅睿（MARIE-ANDRÉE GAMACHE）指出，中国是皮尔法伯最重要的战略市场之一。与国药控股这一行业巨头建立战略伙伴关系，是其深耕中国市场的重要里程碑。国药控股无与伦比的渠道覆盖和市场领导力，将极大提升皮尔法伯制药产品的可及性。她期待通过此次合作，将皮尔法伯 “以患者为中心”的承诺更深入地带给中国患者，为他们的健康保驾护航。此次战略合作协议的签署，双方将充分发挥各自资源优势，深化在中国医药健康市场的布局，为中国人民提供更优质、更广泛的健康产品与服务，携手开启合作共赢的新篇章。关于“皮尔法伯”皮尔法伯是欧洲领先的制药企业之一。皮尔法伯制药业务覆盖肿瘤学、皮肤病学、罕见病、基础医疗及家庭健康护理五大领域。40 余年来，皮尔法伯已成为全球肿瘤学领域的重要参与者，在该领域构建 了从研发到商业化的全产业链布局，其肿瘤学产品涵盖结直肠癌、乳腺癌、 肺癌、皮肤癌以及某些血液恶性肿瘤和癌前皮肤病（如光化性角化症）。供稿：国控全采","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588093980","isCrawlerRequest":true}

法伯精诚 国药匠心——国药控股与皮尔法伯制药达成战略合作

精彩评论

法伯精诚国药匠心——国药控股与皮尔法伯制药达成战略合作